SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-048085
Filing Date
2022-08-15
Accepted
2022-08-15 16:43:20
Documents
50
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_pasitheatherap.htm   iXBRL 10-Q 571716
2 MEMBERSHIP INTEREST PURCHASE AGREEMENT ENTERED INTO JUNE 21, 2022, BY AND AMONG f10q0622ex2-01_pasithea.htm EX-2.1 287708
3 CERTIFICATION f10q0622ex31-1_pasithea.htm EX-31.1 9779
4 CERTIFICATION f10q0622ex31-2_pasithea.htm EX-31.2 9842
5 CERTIFICATION f10q0622ex32-1_pasithea.htm EX-32.1 3871
6 CERTIFICATION f10q0622ex32-2_pasithea.htm EX-32.2 3953
  Complete submission text file 0001213900-22-048085.txt   4179966

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ktta-20220630.xsd EX-101.SCH 38555
8 XBRL CALCULATION FILE ktta-20220630_cal.xml EX-101.CAL 23073
9 XBRL DEFINITION FILE ktta-20220630_def.xml EX-101.DEF 188051
10 XBRL LABEL FILE ktta-20220630_lab.xml EX-101.LAB 398187
11 XBRL PRESENTATION FILE ktta-20220630_pre.xml EX-101.PRE 199559
44 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_pasitheatherap_htm.xml XML 458411
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40804 | Film No.: 221166267
SIC: 2834 Pharmaceutical Preparations